News > Johnson & Johnson applies for approval of single-dose vaccine in India

Johnson & Johnson applies for approval of single-dose vaccine in India

Scroll | 06/08/2021 03:43 PM | Click to read full article

Pharmaceutical company Johnson & Johnson on Thursday applied to the Indian government for emergency-use authorisation of its single-dose coronavirus vaccine. Johnson & Johnson will collaborate with Hyderabad-based Biological E Limited to launch the vaccine in India and other countries across the world.

In phase three clinical trials, the single-shot vaccine showed 85% efficacy in preventing severe disease, Johnson & Johnson said.